A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1998
10/20/1998	US5824487 Method for screening for targets for anti-inflammatory or anti-allergic agents
10/20/1998	US5824486 Identification of agents that regulate glycine transport in or out of cells
10/20/1998	US5824484 RXR homodimer formation
10/20/1998	US5824482 Detection of antibodies for lav virus and antigens doe diagnosis with peptides
10/20/1998	US5824466 Can be used for in vitro detection of skin disorders, cancers
10/20/1998	US5824331 Bioartificial devices and cellular matrices therefor
10/20/1998	US5824330 Highly purified interleukin-2 and method
10/20/1998	US5824318 Avirulent herpetic viruses useful as tumoricidal agents and vaccines
10/20/1998	US5824315 And complexs between them; attaching n-terminus of the peptide epitope a hydrophobic amino acid or peptide containing it; treatment of autoimmune diseases
10/20/1998	US5824311 Treatment of tumors with monoclonal antibodies against oncogene antigens
10/20/1998	US5824309 Peptides inserted into the frame of structural protein
10/20/1998	US5824307 Human-murine chimeric antibodies against respiratory syncytial virus
10/20/1998	US5824306 Dirofilaria and brugia ankyrin proteins, nucleic acid molecules, and uses thereof
10/20/1998	US5824305 Bromelain protease of amino acid sequences as bactericides,anticarcinogenic agents, antiinflammatory agents or atherosclerosis
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/20/1998	US5824303 Dna sequence encoding, proteins and peptides
10/20/1998	US5824300 Treatment of neoplastic disease with oral interferon
10/20/1998	US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis
10/20/1998	US5824297 Administering transforming growth factor beta to cancer patients before chemotherapy; side effect reduction of oraland gastrointestinal mucositis
10/20/1998	US5824230 Purifying by depositing a thin layer film of non-crosslinked fibrin polymer onto outer wall coupling with a enzyme, dissolving with an acid buffer, depolymerizing to fibrin coagulants
10/20/1998	US5824087 Bone regeneration
10/20/1998	CA2103163C Compositions and methods for the sublingual or buccal administration of therapeutic agents
10/20/1998	CA1340097C Synthetic antigen for detection of aids-related disease
10/20/1998	CA1340096C Analogs of atrial natriuretic peptides
10/18/1998	CA2203085A1 5-phosphatase type-ii and implication in alzheimer's disease
10/18/1998	CA2203070A1 Chromosome 6 gene and gene products related to alzheimer's disease
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045711A2 Assay for ligands to tyrosine kinase receptors
10/15/1998	WO1998045468A1 Production of functional proteins: balance of shear stress and gravity
10/15/1998	WO1998045467A1 NOVEL TGF-β PATHWAY GENES
10/15/1998	WO1998045443A1 Radioisotope concentrator methods and compositions
10/15/1998	WO1998045441A1 Human gtp binding protein
10/15/1998	WO1998045440A1 Human fatty acid binding protein
10/15/1998	WO1998045439A1 Human tumor-associated membrane protein
10/15/1998	WO1998045438A1 Ucp3: an uncoupling protein homologue
10/15/1998	WO1998045434A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998	WO1998045433A1 Proteins and compositions for modulating mitosis
10/15/1998	WO1998045432A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	WO1998045430A1 Immune modulation by polypeptides related to cr1
10/15/1998	WO1998045429A2 Polypeptides involved in the staurosporine induced apoptotic pathway
10/15/1998	WO1998045428A1 Fanconi-gen ii
10/15/1998	WO1998045427A2 Insulin-like growth factor agonist peptides
10/15/1998	WO1998045420A1 Pca3, pca3 genes, and methods of use
10/15/1998	WO1998045416A1 Thioredoxin-like protein
10/15/1998	WO1998045332A2 Humanized antibodies and methods for forming humanized antibodies
10/15/1998	WO1998045331A2 Anti-vegf antibodies
10/15/1998	WO1998045329A1 Natriuretic peptide derivatives
10/15/1998	WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	WO1998045327A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis
10/15/1998	WO1998045325A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	WO1998045323A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/15/1998	WO1998045322A2 Diagnosis method and reagents
10/15/1998	WO1998045320A1 Novel hexadepsipeptide compounds
10/15/1998	WO1998045319A2 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN α-CATENIN and β-CATENIN
10/15/1998	WO1998045318A1 Activated peptides and conjugates
10/15/1998	WO1998045314A1 Composition and method for treatment of cmv infections
10/15/1998	WO1998045313A1 Novel uncoupling protein and methods of use
10/15/1998	WO1998045312A1 Serogroup-specific nucleotide sequences in the molecular typing of bacterial isolates and the preparation of vaccines thereto
10/15/1998	WO1998045284A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
10/15/1998	WO1998045257A1 Thio derivatives as naaladase inhibitors
10/15/1998	WO1998045256A1 Hydroxamic acid derivatives
10/15/1998	WO1998044955A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998	WO1998044954A1 Metal ion transporter and uses therefor
10/15/1998	WO1998044953A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998	WO1998044948A2 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
10/15/1998	WO1998044942A1 Immunotolerant prothrombin complex preparation
10/15/1998	WO1998044941A1 Method for inactivating pathogens, especially viruses, in a biological material
10/15/1998	WO1998044940A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	WO1998044934A1 Cytokine and cisplatin-based gene therapy of carcinomas
10/15/1998	WO1998044929A1 Composition comprising a hydrolysed collagen protein and glucosamine for the treatment of arthroses
10/15/1998	WO1998044908A1 Method of regulating epithelial growth
10/15/1998	WO1998044904A1 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein
10/15/1998	WO1998044893A2 Method and formulation for treating vascular disease
10/15/1998	WO1998044809A1 Improved process for the manufacture of collagen
10/15/1998	WO1998044793A1 Non-steroidal anabolic composition
10/15/1998	WO1998035693A3 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
10/15/1998	WO1998030589A3 Secreted proteins and polynucleotides encoding them
10/15/1998	WO1998029134A3 Microporation of tissue for delivery of bioactive agents
10/15/1998	WO1998029105A3 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
10/15/1998	WO1998027963A3 Gel composition and methods
10/15/1998	WO1998025962A3 Secreted proteins and polynucleotides encoding them
10/15/1998	WO1998024887A3 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/15/1998	WO1998024807A3 Somatostatin antagonists
10/15/1998	WO1998024806A3 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
10/15/1998	WO1998022588A3 An improved method for the production and purification of adenoviral vectors
10/15/1998	WO1998022500A3 Modulation of interactions between myosin and integrins
10/15/1998	WO1998018925A3 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
10/15/1998	WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998	DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances
10/15/1998	DE19715149A1 Krebstherapeutikum und Diagnose zur Charakterisierung von Krebszellen mit individueller Eigenschaft Cancer therapy and diagnosis for the characterization of cancer cells with individual property
10/15/1998	CA2287778A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	CA2287084A1 Diagnosis method and reagents
10/15/1998	CA2286860A1 Radioisotope concentrator methods and compositions
10/15/1998	CA2286390A1 Human tumor-associated membrane protein
10/15/1998	CA2286349A1 Production of functional proteins: balance of shear stress and gravity
10/15/1998	CA2286348A1 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	CA2286346A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	CA2286305A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998	CA2286303A1 20 human secreted proteins
10/15/1998	CA2286291A1 Compounds and methods for inhibiting the interaction between a-catenin and b-catenin

1 ... 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 ... 3163